104 related articles for article (PubMed ID: 3297144)
1. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.
Prass W; Ringsdorf H; Bessler W; Wiesmüller KH; Jung G
Biochim Biophys Acta; 1987 Jun; 900(1):116-28. PubMed ID: 3297144
[TBL] [Abstract][Full Text] [Related]
2. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins.
Biesert L; Scheuer W; Bessler WG
Eur J Biochem; 1987 Feb; 162(3):651-7. PubMed ID: 3549292
[TBL] [Abstract][Full Text] [Related]
3. Binding of a synthetic analogue of mitogenic bacterial lipoprotein to murine major histocompatibility complex (MHC) gene products.
Scheuer WV; Biesert L; Bessler WG
Biol Chem Hoppe Seyler; 1986 Oct; 367(10):1085-94. PubMed ID: 3491614
[TBL] [Abstract][Full Text] [Related]
4. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein.
Bessler WG; Johnson RB; Wiesmüller K; Jung G
Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983
[TBL] [Abstract][Full Text] [Related]
5. Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli.
Bessler W; Resch K; Hancock E; Hantke K
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):11-22. PubMed ID: 325934
[TBL] [Abstract][Full Text] [Related]
6. Biological activity of the Escherichia coli lipoprotein: detection of novel lymphocyte activating peptide segments of the molecule and their conformational characterization.
Loleit M; Deres K; Wiesmüller KH; Jung G; Eckert M; Bessler WG
Biol Chem Hoppe Seyler; 1994 Jun; 375(6):407-12. PubMed ID: 7980873
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new P3CS derivatives and their mitogenic activity on in vitro mice splenocytes.
Pappalardo M; Bousquet E; Annino A; Lombardo G; Bernardini R; Ronsisvalle G
Farmaco; 2003 Apr; 58(4):329-36. PubMed ID: 12727543
[TBL] [Abstract][Full Text] [Related]
8. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala).
Bessler WG; Cox M; Wiesmüller KH; Jung G
Biochem Biophys Res Commun; 1984 May; 121(1):55-61. PubMed ID: 6375670
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein.
Brade L; Bessler WG; Brade H
Infect Immun; 1988 May; 56(5):1382-4. PubMed ID: 3281910
[TBL] [Abstract][Full Text] [Related]
10. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.
Lex A; Wiesmüller KH; Jung G; Bessler WG
J Immunol; 1986 Oct; 137(8):2676-81. PubMed ID: 3531339
[TBL] [Abstract][Full Text] [Related]
11. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
[TBL] [Abstract][Full Text] [Related]
12. Interaction of immunologically-active lipopeptides with membranes.
Metzger JW; Sawyer WH; Wille B; Biesert L; Bessler WG; Jung G
Biochim Biophys Acta; 1993 Jun; 1149(1):29-39. PubMed ID: 8391319
[TBL] [Abstract][Full Text] [Related]
13. Mitogenic activity and the induction of tumor necrosis factor by lipopeptide analogs of the N-terminal part of lipoprotein in the outer membrane of Escherichia coli.
Shimizu T; Iwamoto Y; Yanagihara Y; Kurimura M; Achiwa K
Biol Pharm Bull; 1994 Jul; 17(7):980-2. PubMed ID: 8000390
[TBL] [Abstract][Full Text] [Related]
14. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo.
Johnson RB; Köhl S; Wiesmüller K; Jung G; Bessler WG
Immunobiology; 1983 Jul; 165(1):27-35. PubMed ID: 6350164
[TBL] [Abstract][Full Text] [Related]
15. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.
Melchers F; Braun V; Galanos C
J Exp Med; 1975 Aug; 142(2):473-82. PubMed ID: 1095681
[TBL] [Abstract][Full Text] [Related]
16. Synthetic lipopeptide immunomodulators derived from bacterial lipoprotein: tools for the standardization of in vitro assays.
Bessler WG
Dev Biol Stand; 1992; 77():49-56. PubMed ID: 1426672
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
[TBL] [Abstract][Full Text] [Related]
18. Polyclonal activation of B-lymphocytes in vivo by Salmonella typhimurium lipoprotein.
Johnson RB; Köhl S; Bessler WG
Infect Immun; 1983 Mar; 39(3):1481-4. PubMed ID: 6341238
[TBL] [Abstract][Full Text] [Related]
19. Mitogenicity of a lipid-deficient lipoprotein from a mutant Escherichia coli strain.
Bessler WG; Simon E; Rotering H
Infect Immun; 1980 Jun; 28(3):818-23. PubMed ID: 6995322
[TBL] [Abstract][Full Text] [Related]
20. Lipopeptide-polyoxyethylene conjugates as mitogens and adjuvants.
Kleine B; Rapp W; Wiesmüller KH; Edinger M; Beck W; Metzger J; Ataulakhanov R; Jung G; Bessler WG
Immunobiology; 1994 Feb; 190(1-2):53-66. PubMed ID: 8082887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
